Search - tctmd.com

Displaying 141 - 160 of 199

Sort: Relevancy | Date

Presentation TCT 2012

Vignettes on Plaque Stability 2: Insights from Serial Imaging in IBIS II

Presenter: Hector Garcia-Garcia

October 23, 2012

Presentation TCT 2012

Vignettes on Plaque Stability 1: Insights from the VH Registry and HORIZONS-AMI

Presenter: Akiko Maehara

October 23, 2012

Presentation TCT 2012

Therapies Based on ApoA1 and ApoA1 Milano: Overview of the Field

Presenter: Bryan Brewster

October 23, 2012

Presentation TCT 2012

The Vulnerable Mind: Connections Between the Cortex and Coronaries

Presenter: Amir Lerman

October 23, 2012

Presentation TCT 2012

The HDL Hypothesis: A Critical Reappraisal

Presenter: Robert Wilensky

October 23, 2012

Presentation TCT 2012

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

Presenter: Jonathon Leipsic

October 23, 2012

Presentation TCT 2012

TCT-24. Combined Near-Infrared Spectroscopic and Intravascular Ultrasound Assessment of Coronary Plaque Burden and Lipid Pools: Validation with Histology

Presenter: Rishi Puri

October 23, 2012

Presentation TCT 2012

TCT-23. Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction

Presenter: Ryan Madder

October 23, 2012

Presentation TCT 2012

TCT-22. Combination of High Wall Shear Stress, Plaque Burden, and Plaque Phenotype has Incremental Value for Prediction of Increased Plaque Vulnerability in Patients with...

Presenter: Michel Corban

October 23, 2012

Presentation TCT 2012

Statement: Molecular Imaging Will Transform the Evaluation of Atherosclerosis

Presenter: Farouc Jaffer

October 23, 2012

Presentation TCT 2012

Should VH-IVUS Be Used as a Clinical Tool to Detect and Treat Vulnerable Plaque TODAY: From PROSPECT to VIVA

Presenter: Patrick Calvert

October 23, 2012

Presentation TCT 2012

Reevaluating the Radiation Risk of CT Angiography

Presenter: Andrew Einstein

October 23, 2012

Presentation TCT 2012

Potential Role for Pan-Vascular Imaging: Insights from the HRP Project

Presenter: Valentin Fuster

October 23, 2012

Presentation TCT 2012

PCSK9 Inhibitors: The Holy Grail?

Presenter: Evan Stein

October 23, 2012

Presentation TCT 2012

Pathogenesis of Vulnerable Plaque 2012: What's New?

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies

Presenter: Shiro Uemura

October 23, 2012

Presentation TCT 2012

NIRS as a Clinical Tool for Vulnerable Plaque Detection: Findings in Patients with Acute STEMI

Presenter: Ryan Madder

October 23, 2012

Presentation TCT 2012

Nanoparticle-based Therapies for Atherosclerosis: The NANOM FIM Study

Presenter: Alexander Kharlamov

October 23, 2012

Presentation TCT 2012

Most Diseases Are Systemic: It's the Focal Manifestations that Count!

Presenter: James Muller

October 23, 2012

Presentation TCT 2012

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Presenter: Bernard De Bruyne

October 23, 2012

Advertisement

Vignettes on Plaque Stability 2: Insights from Serial Imaging in IBIS II

Vignettes on Plaque Stability 1: Insights from the VH Registry and HORIZONS-AMI

Therapies Based on ApoA1 and ApoA1 Milano: Overview of the Field

The Vulnerable Mind: Connections Between the Cortex and Coronaries

The HDL Hypothesis: A Critical Reappraisal

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

TCT-24. Combined Near-Infrared Spectroscopic and Intravascular Ultrasound Assessment of Coronary Plaque Burden and Lipid Pools: Validation with Histology

TCT-23. Detection by Near-infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients with Acute ST-Segment Elevation Myocardial Infarction

TCT-22. Combination of High Wall Shear Stress, Plaque Burden, and Plaque Phenotype has Incremental Value for Prediction of Increased Plaque Vulnerability in Patients with...

Statement: Molecular Imaging Will Transform the Evaluation of Atherosclerosis

Should VH-IVUS Be Used as a Clinical Tool to Detect and Treat Vulnerable Plaque TODAY: From PROSPECT to VIVA

Reevaluating the Radiation Risk of CT Angiography

Potential Role for Pan-Vascular Imaging: Insights from the HRP Project

PCSK9 Inhibitors: The Holy Grail?

Pathogenesis of Vulnerable Plaque 2012: What's New?

OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies

NIRS as a Clinical Tool for Vulnerable Plaque Detection: Findings in Patients with Acute STEMI

Nanoparticle-based Therapies for Atherosclerosis: The NANOM FIM Study

Most Diseases Are Systemic: It's the Focal Manifestations that Count!

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content